This is supported by a recent report which indicates that even when the bromodomain of BRD4 is inhibited, its interaction with transcriptional co-activators in breast cancer is unimpeded due to the presence of a longer isoform capable of maintaining protein-protein interactions [45]. Here, BRD4 is linked to breast cancer.